Creative Biolabs is accelerating gene therapy research globally with specialized expertise. SHIRLEY, NY, UNITED STATES, ...

Circular Genomics, a molecular diagnostics company pioneering circular RNA (circRNA)–based biomarkers for neurodegenerative disease, today announced the completion of exclusive intellectual property ...

Feb 9 (Reuters) - Eli Lilly will buy therapy developer Orna Therapeutics for up to $2.4 billion in cash, the companies said ...

Eli Lilly (NYSE:LLY) announced the acquisition of Orna Therapeutics to expand into circular RNA based gene and autoimmune ...

Diabetic foot ulcers are slow-healing and increase the risk of infections and amputation. Researchers at Karolinska ...

Deep within our nerve cells, a molecule is at work that has no beginning and no end. Instead of a straight chain, as is common for most RNA strands, it forms a closed loop. Known as circular RNAs ...

Eli Lilly (LLY) stock acquiring Orna Therapeutics for up to $2.4 billion to develop circular RNA CAR-T therapies for B ...

A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor biology and a promising avenue for future therapies.

Eli Lilly (LLY) has agreed to acquire biotechnology company Orna Therapeutics for up to $2.4B in cash, inclusive of an ...

Exploring use of Altamira’s RNA nanoparticles in conjunction with circular RNA payloads Project collaboration partner will have option to negotiate licensing agreement Altamira Therapeutics Ltd.

Over the past few decades, RNA’s place in biology has transformed from being a mere intermediate between DNA and protein to a fascinating molecule with diverse activities that go well beyond simple ...